Fortis Healthcare

Fortis Healthcare

964.50
-3.20
(-0.33%)
Market Cap
72,815.71 Cr
EPS
10.26
PE Ratio
79.08
Dividend Yield
0.10 %
52 Week High
983.20
52 Week Low
572.00
PB Ratio
8.20
Debt to Equity
0.22
Sector
Hospitals
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from13 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %

Company News

View All News
Caret
neutral
Fortis Healthcare announced board changes effective September 09, 2025. Dr. Keith Hsiu Chin Lim was appointed as Additional Director (Non-Executive & Non-Independent) based on the Nomination and Remuneration Committee's recommendation. Simultaneously, Tomo Nagahiro resigned from his position as Non-Executive & Non-Independent Director due to other commitments and responsibilities. Dr. Lim serves as Group Chief Medical Officer at IHH Healthcare and holds over 20 years of experience as a radiation oncologist. He previously worked with National University Health System and Singapore's Ministry of Health, receiving Singapore's National Medical Excellence Award. Dr. Lim is not related to other company directors but serves as a nominee director of Northern TK Venture Pte. Ltd along with several other board members.
positive
Fortis Healthcare has entered into an agreement for hospital land and equipment lease in Greater Noida. The agreement involves UPSIDA and R.R. Lifesciences Pvt Ltd as the other parties to the deal.
positive
Fortis Healthcare has taken control of a 200-bed hospital in Greater Noida through a long-term lease arrangement. This expansion increases the company's total bed capacity in the Delhi-NCR region to approximately 2,000 beds. The move is aimed at providing wider healthcare access and enhancing collaborations in the region.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
7,716.50
#1 1,10,951.43
70.21
#1 21,994.30
14.76
#1 1,505
39.78
49.52
1,135.80
1,10,416.44
93.82
7,184.10
#1 28.68
1,076
30.34
45.93
964.50
#3 72,815.71
#7 79.08
#2 7,849.70
#8 13.25
#3 809
#1 53.33
61.38
1,324.20
35,566.34
62.27
3,771.40
21.40
481
49.58
42.76
1,720.10
35,152.10
44.80
5,575.00
12.29
790
-2.38
41.52
634.00
32,848.87
92.33
4,286.70
15.12
337
-98.18
62.31
728.30
29,142.12
79.88
3,067.00
21.98
415
-10.71
47.61
6,350.00
16,902.36
#1 31.12
599.90
11.69
58
24.89
52.63
1,398.50
14,202.00
55.85
1,566.90
17.46
244
35.52
26.76
1,526.00
10,005.37
50.49
1,290.20
17.77
194
-1.57
59.23
Forecast
Actual
Growth Rate
Revenue Growth
13.25 %
Net Income Growth
25.45 %
Cash Flow Change
29.44 %
ROE
17.11 %
ROCE
0.92 %
EBITDA Margin (Avg.)
11.89 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
1,085
1,152
1,150
1,024
1,106
1,176
1,257
1,630
1,164
1,229
1,258
1,175
1,108
1,081
1,156
1,164
1,528
1,170
1,277
1,178
1,133
614
1,029
1,205
1,278
1,733
1,475
1,487
1,391
1,519
1,682
1,586
1,669
1,667
1,788
1,699
1,803
1,873
2,006
1,975
2,032
2,198
Expenses
1,022
986
1,087
1,066
1,091
1,059
1,097
1,023
1,045
1,071
1,138
1,069
1,907
1,034
1,172
1,193
1,069
996
1,028
1,012
987
709
875
987
1,055
1,135
1,178
1,180
1,157
1,237
1,304
1,283
1,372
1,386
1,440
1,396
1,405
1,516
1,613
1,553
1,625
1,676
EBITDA
62
166
62
-42
15
118
160
607
118
158
120
106
-799
47
-16
-29
459
174
250
166
146
-96
155
218
223
598
297
307
234
282
378
302
297
282
349
303
398
356
393
422
406
522
Operating Profit %
3 %
4 %
-2 %
-5 %
-2 %
6 %
8 %
10 %
7 %
7 %
5 %
5 %
-76 %
1 %
-3 %
-8 %
10 %
13 %
15 %
13 %
11 %
-17 %
12 %
16 %
16 %
20 %
19 %
20 %
16 %
17 %
19 %
18 %
16 %
16 %
19 %
17 %
21 %
18 %
19 %
19 %
19 %
23 %
Depreciation
61
53
0
0
72
48
52
60
63
59
61
59
60
57
56
60
60
71
71
70
80
72
74
73
72
73
75
76
77
74
77
83
82
79
84
87
92
91
95
97
102
102
Interest
37
34
30
32
38
42
46
75
67
64
66
63
64
76
85
111
65
51
49
48
57
41
42
42
41
38
40
38
30
31
33
33
32
32
32
33
35
35
36
45
68
70
Profit Before Tax
-22
88
44
-58
-96
28
62
472
-11
35
-7
-17
-924
-87
-157
-201
334
52
130
48
9
-208
38
103
110
486
182
193
126
176
268
186
183
171
233
183
271
230
261
279
237
351
Tax
-10
-9
-17
-29
-8
3
24
19
26
12
17
3
-9
-34
-15
-20
183
-26
6
118
50
-20
23
49
48
56
51
51
39
42
50
44
45
47
49
49
68
56
68
25
49
84
Net Profit
-12
97
61
-29
-88
25
38
453
-38
23
-24
-19
-914
-53
-142
-180
151
78
124
-69
-41
-188
16
54
62
431
131
142
87
134
218
142
138
124
184
134
203
174
193
254
188
267
EPS in ₹
-0.38
2.01
1.19
-0.65
-1.91
0.35
0.68
9.49
-0.79
0.10
-0.88
-0.71
-17.97
-1.36
-3.21
-3.06
1.80
0.90
1.47
-1.01
-0.59
-2.37
-0.05
0.40
0.57
3.49
1.42
1.55
0.90
1.62
2.71
1.72
1.76
1.48
2.30
1.78
2.37
2.20
2.34
3.28
2.44
3.45

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
7,616
7,232
9,717
8,622
11,951
11,348
11,155
11,885
12,434
13,289
13,692
Fixed Assets
4,218
3,776
5,419
4,992
8,477
8,802
8,799
9,416
9,426
9,874
10,424
Current Assets
1,636
1,434
1,775
1,282
1,667
941
1,037
1,133
1,406
1,421
1,471
Capital Work in Progress
228
201
268
226
450
204
165
194
228
542
407
Investments
616
1,449
1,878
1,732
270
175
186
104
210
230
169
Other Assets
2,554
1,807
2,152
1,672
2,755
2,167
2,005
2,172
2,569
2,643
2,692
Total Liabilities
7,616
7,232
9,717
8,622
11,951
11,348
11,155
11,885
12,434
13,289
13,692
Current Liabilities
1,602
1,476
1,927
2,134
3,591
2,579
1,233
1,269
1,426
3,170
1,607
Non Current Liabilities
1,813
1,616
1,480
1,171
1,248
1,563
3,204
3,607
2,907
1,563
2,915
Total Equity
4,201
4,140
6,311
5,317
7,113
7,206
6,718
7,008
8,100
8,556
9,169
Reserve & Surplus
3,585
3,534
4,626
3,543
5,846
5,906
5,365
5,423
6,487
6,908
8,162
Share Capital
463
463
518
519
755
755
755
755
755
755
755

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
-66
-38
225
-513
799
-627
212
-153
-22
125
-70
Investing Activities
213
122
-1,001
-333
-3,279
64
-131
-501
-373
-889
-780
Operating Activities
24
195
967
493
-179
172
486
865
822
1,100
1,424
Financing Activities
-304
-354
259
-672
4,257
-862
-143
-517
-471
-87
-714

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
26.32 %
0.00 %
23.24 %
23.31 %
25.26 %
26.77 %
27.40 %
27.17 %
DIIs
13.44 %
15.20 %
15.66 %
15.50 %
16.72 %
17.44 %
19.94 %
20.38 %
20.70 %
22.16 %
26.55 %
29.35 %
31.15 %
32.31 %
30.73 %
30.05 %
29.46 %
29.79 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
13.96 %
15.16 %
15.98 %
14.89 %
13.96 %
13.58 %
12.92 %
12.39 %
12.05 %
11.80 %
11.13 %
11.04 %
10.82 %
10.47 %
10.36 %
10.21 %
10.22 %
10.17 %
Others
41.43 %
38.47 %
37.20 %
38.44 %
38.15 %
37.82 %
35.98 %
36.06 %
36.08 %
34.86 %
4.83 %
28.44 %
3.63 %
2.75 %
2.48 %
1.81 %
1.75 %
1.70 %
No of Share Holders
0
1,09,889
1,44,634
1,66,743
1,54,572
1,56,881
1,60,762
1,58,455
1,37,894
1,35,047
1,31,516
1,35,664
1,57,165
1,54,260
2,04,184
2,21,750
2,18,329
2,05,373

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1 1 1
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.24 0.14 0.1

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
20 Jul 2023 DIVIDEND Dividend
₹ 1.00 /share
20 Jul 2023 289.05 328.75
24 Jul 2024 DIVIDEND Dividend
₹ 1.00 /share
24 Jul 2024 469.50 487.45
02 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
02 Aug 2024 471.55 505.05
08 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
08 Nov 2024 601.65 623.10
07 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Feb 2025 581.00 651.05
20 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
20 May 2025 682.75 685.85
25 Jul 2025 DIVIDEND Dividend
₹ 1.00 /share
25 Jul 2025 685.85 846.55
06 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Aug 2025 850.05 867.90
11 Aug 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
11 Aug 2025 773.45 897.45

Announcements

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation6 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation6 days ago
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 11, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateSep 09, 2025
Status Of Re-Lodgement Of Transfer Requests Of Physical Shares For The Months Ended On 31St July 2025 And 31St August 2025.Sep 08, 2025
Execution Of Tripartite Agreement Among Uttar Pradesh Industrial Development Authority (UPSIDA) R.R. Lifesciences Pvt Ltd And International Hospital Limited (IHL)Sep 05, 2025
Announcement under Regulation 30 (LODR)-Credit RatingSep 01, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseSep 01, 2025
Execution Of Sub-Lease Agreement With R.R. Lifesciences Pvt LtdSep 01, 2025
Effective Date Of Scheme Of ArrangementSep 01, 2025
Announcement under Regulation 30 (LODR)-Scheme of ArrangementSep 01, 2025
Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations) - Intimation Of Revision In ESG Rating Assigned By CRISILAug 25, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 20, 2025
Special Window For Re-Lodgement Of Transfer Requests Of Physical SharesAug 20, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportAug 11, 2025
Appointment Of M/S Neelam Gupta & Associates Company Secretaries (Firm Registration No. S2006DE086800) Who Is A Peer Reviewed Company Secretary In Practice As Secretarial Auditors Of The Company For A Term Of 5 (Five) Consecutive Years Commencing From FinAug 11, 2025
Summary Of Proceedings Of The 29Th Annual General Meeting Of The Company Held On Monday August 11 2025 At 14:00 Hours (IST) Through Video Conferencing/ Other Audio Visual Means (VC/OAVM) Aug 11, 2025
Summary Of The Proceedings Of The 29Th Annual General Meeting Of The Company Held On Monday August 11 2025 At 14:00 Hours (IST) Through Video Conferencing/ Other Audio Visual Means (VC/OAVM)Aug 11, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMAug 11, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 07, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 07, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementAug 06, 2025
Compliances-Reg. 54 - Asset Cover details Aug 06, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationAug 06, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 06, 2025
Outcome Of The Board Meeting Under Regulation 30 33 Regulation 51(2) And 52 Of Securities Andexchange Board Of India (Listing Obligations & Disclosure Requirements) Regulations 2015Aug 06, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Under Regulation 30 33 Regulation 51(2) And 52 Of Securities And Exchange Board Of India (Listing Obligations & Disclosure Requirements) Regulations 2015Aug 06, 2025
Announcement under Regulation 30 (LODR)-Scheme of ArrangementJul 31, 2025
Approval Of Scheme Of Arrangement By HonBle NCLTJul 31, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 31, 2025
Board Meeting Intimation for Prior Intimation Of Board Meeting Under Regulation 29 And 50 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jul 30, 2025
Update On Consummation Of Shrimann Superspecialty Hospital TransactionJul 24, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 23, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 23, 2025
Intimation On Operation And Maintenance Services Agreement With Gleneagles Healthcare India Private LimitedJul 23, 2025
Update On SRL TrademarksJul 20, 2025
Intimation On Tax Deduction At Source (TDS)/Withholding Tax On DividendJul 17, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 15, 2025
Letters Contain The Weblink To Access The Annual Report Of Financial Year 2024-25Jul 14, 2025
Announcement under Regulation 30 (LODR)-Dividend UpdatesJul 14, 2025
Announcement under Regulation 30 (LODR)-Date of payment of DividendJul 14, 2025
Record Date Fixed For Dividend PaymentJul 14, 2025
Please Find Enclosed The Intimation Of Date Of Closure Of Register Of Members & Share Transfer BookJul 14, 2025
Business Responsibility and Sustainability Reporting (BRSR)Jul 14, 2025
Regulation 53 (1) Annual Report.Jul 14, 2025
Reg. 34 (1) Annual Report.Jul 14, 2025
Intimation Of Notice Of 29Th AGM Of Fortis Healthcare Limited To Be Held On August 11 2025Jul 14, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 14, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 11, 2025

Technical Indicators

RSI(14)
Neutral
61.84
ATR(14)
Less Volatile
19.05
STOCH(9,6)
Neutral
57.32
STOCH RSI(14)
Neutral
20.63
MACD(12,26)
Bearish
-2.88
ADX(14)
Strong Trend
39.91
UO(9)
Bearish
54.16
ROC(12)
Uptrend And Accelerating
2.09
WillR(14)
Neutral
-29.19

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Aditya Birla Sun Life ELSS Tax Saver Direct-Growth
3.26%
-2192577
-0.98%
-0.56%
SBI ELSS Tax Saver Fund Direct-Growth
0.63%
-2000000
-0.53%
-0.43%
Tata Large & Mid Cap Fund Direct Plan-Growth
1.29%
-1300000
-1.15%
-1.91%
Axis Small Cap Fund Direct-Growth
0.30%
-1259199
-0.39%
-0.33%
Mirae Asset Midcap Fund Direct - Growth
0.05%
-1164962
-0.58%
-0.72%
HDFC Mid Cap Fund Direct-Growth
2.96%
1092893
0.31%
0.55%
Aditya Birla Sun Life Mid Cap Direct Fund-Growth
3.18%
-738485
-0.78%
-0.43%
Mahindra Manulife Multi Cap Fund Direct - Growth
1.52%
675000
1.13%
1.52%
Kotak Arbitrage Fund Direct-Growth
0.42%
-656425
-0.06%
0.03%
Aditya Birla Sun Life Consumption Direct Fund-Growth
0.55%
-420936
-0.55%
-0.47%
HDFC Arbitrage Fund Wholesale Direct-Growth
0.14%
317750
0.13%
0.13%
Nippon India Vision Large & Mid Cap Direct-Growth
0.00%
-312523
-0.43%
-0.40%
Axis Large & Mid Cap Fund Direct-Growth
2.12%
300000
0.31%
0.66%
Invesco India Arbitrage Fund Direct-Growth
0.58%
-281325
-0.09%
-0.01%
Mahindra Manulife Large & Mid Cap Fund Direct - Growth
0.91%
260000
0.91%
0.91%
Aditya Birla Sun Life Large & Mid Cap Fund Direct -Growth
1.50%
-250891
-0.26%
-0.08%
Aditya Birla Sun Life MNC Fund Direct-Growth
2.30%
-229387
-0.36%
-0.16%
WhiteOak Capital Mid Cap Fund Direct - Growth
2.99%
217519
0.64%
0.94%
Baroda BNP Paribas Health and Wellness Fund Direct-Growth
1.43%
-215000
-2.60%
0.17%
Mahindra Manulife Mid Cap Fund Direct - Growth
1.02%
200000
0.51%
1.02%
Samco Active Momentum Fund Direct - Growth
2.20%
198000
2.20%
2.20%
SBI Arbitrage Opportunities Fund Direct-Growth
0.10%
169725
0.04%
0.06%
Bandhan Midcap Fund Direct-Growth
2.83%
149026
0.86%
1.69%
Aditya Birla Sun Life Equity Hybrid '95 Fund Direct-Growth
0.44%
-145037
-0.13%
-0.16%
WhiteOak Capital Flexi Cap Fund Direct - Growth
0.20%
125131
0.20%
0.20%

About Fortis Healthcare

Fortis Healthcare Limited is one of India's largest healthcare providers, operating 27 hospitals with 4,500 operational beds and over 426 diagnostics centres as of March 31, 2023. The company offers a wide range of integrated healthcare services including cardiac care, orthopedics, neurosciences, oncology, renal care, gastroenterology, and mother and child care. Fortis uses advanced technology to deliver quality healthcare in modern facilities. Its subsidiary, SRL Limited, is a leading diagnostics chain in India. Fortis Healthcare has a presence in India, Dubai, Mauritius, and Sri Lanka. The company has expanded through acquisitions and new facility launches over the years, focusing on its core Indian market in recent times. It provides inpatient and outpatient services, sells medical and non-medical items, and offers management services to hospitals. Fortis Healthcare's specialties include cardiac sciences, cosmetology, dental sciences, dermatology, general surgery, oncology, urology, neurosurgery, radiology, orthopedics, and organ transplant.
Listing Date
09 May, 2007(18 Years, 15 days)
Chairperson NameLeo Puri